Friday, September 26, 2008

CPOE v BCMA

There was a thread on this in the AMIA Pharmacoinformatics list serv.

Today, there was a very good teleconference with David Bates and Robert Wachter where the moderator addressed the topic of CPOE versus BCMA was met head on.  Dr Wachter restated his politically based, non-evidenced view from his blog.  Dr. Bates disagreed on two fronts.  First the epidemiological studies are clear – more harm is done from mistakes in prescribing.  Second, the best evidence for safety is with CPOE.  There was agreement that optimally both should be done.  For me the answer seems crystal clear.

No comments:

Post a Comment